The Business Times
SUBSCRIBERS

Drug industry faces era of moderate price increases, says Valeant CEO

Published Fri, Oct 23, 2015 · 09:50 PM
Share this article.

New York

VALEANT Pharmaceuticals International, which has been criticised for raising drug prices and is being investigated by the US government, predicted this week that lower price increases are ahead for the whole industry.

Valeant chief executive J Michael Pearson told investors on Monday that the company's 2016 outlook is based on expectations for a new pricing environment wher…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here